Results 171 to 180 of about 655,147 (306)

Modeling the Clinical Implications of Andexanet Alfa in Factor Xa Inhibitor–Associated Intracerebral Hemorrhage

, 2021
Carlin Chuck, Daniel Kim, Roshini Kalagara, Nathaniel Rex, Tracy E. Madsen, Leana Mahmoud, Bradford Thompson, Richard N. Jones, Karen L. Furie, Michael Reznik   +9 more
openalex   +2 more sources

Discovery of the Novel Antithrombotic Agent 5-Chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939):  An Oral, Direct Factor Xa Inhibitor

, 2005
Susanne Roehrig, Alexander Straub, Jens Pohlmann, Thomas Lampe, Josef Pernerstorfer, Karl‐Heinz Schlemmer, Peter Reinemer, Elisabeth Perzborn   +7 more
openalex   +1 more source

Cauda equina syndrome due to Factor Xa inhibitor (Rivaroxaban): Case report and review of literature

, 2020
SR Gowda, PJ O’Hagan, JT Griffiths
openalex   +2 more sources

Urine-based point-of-care testing for factor-Xa-inhibitors in acute ischemic stroke patients: a feasibility study. [PDF]

Front Neurol, 2023
Doeppner TR, Olbricht L, Maxhuni T, Alhaj Omar O, Sachs UJ, Juenemann MB, Huttner HB, Gerner ST.   +7 more
europepmc   +1 more source

Clinical utility of rivaroxaban in stroke prevention associated with nonvalvular atrial fibrillation – patient considerations

Journal of Blood Medicine, 2014
Ingo Ahrens, Christoph Bode Heart Center, University of Freiburg, Department of Cardiology and Angiology I, Freiburg, Germany Abstract: The direct factor Xa inhibitor rivaroxaban was the first within the group of orally available direct factor Xa ...
Ahrens I, Bode C
doaj  

Andexanet alfa is an effective reversal agent for factor Xa inhibitors in patients that develop intracranial hemorrhage

, 2019
Joseph Friedli
openalex   +2 more sources

New Oral Anticoagulants for Atrial Fibrillation: the Factor Xa Inhibitors Rivaroxaban and Apixaban [PDF]

, 2012
Russell S. Roberson, Andrew Shaw
openalex   +1 more source

Synthesis of 3,4-diaminobenzoyl derivatives as factor Xa inhibitors

, 2015
Jiabin Yang, Guoqiang Su, Yu Ren, Yang Chen   +3 more
openalex   +1 more source

Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor [PDF]

, 2013
Jeanne Mendell, Hamim Zahir, Nobuko Matsushima, Robert J. Noveck, Frank Lee, Shuquan Chen, George Zhang, Minggao Shi   +7 more
openalex   +1 more source

The 5 most frequently asked questions about factor Xa inhibitors. [PDF]

Hematology Am Soc Hematol Educ Program, 2022
Wang TF, Carrier M.
europepmc   +1 more source